Madrigal Pharmaceuticals Inc (MDGL)
208.41
+1.83
(+0.89%)
USD |
NASDAQ |
Oct 04, 16:00
208.42
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Annual): 405.33M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 405.33M |
| December 31, 2022 | 197.39M |
| December 31, 2021 | 196.11M |
| December 31, 2020 | 239.97M |
| December 31, 2019 | 416.56M |
| December 31, 2018 | 476.98M |
| December 31, 2017 | 182.26M |
| December 31, 2016 | 36.41M |
| December 31, 2015 | -48.91M |
| December 31, 2014 | 65.14M |
| December 31, 2013 | 49.09M |
| Date | Value |
|---|---|
| December 31, 2012 | 75.07M |
| December 31, 2011 | 14.77M |
| December 31, 2010 | 23.48M |
| December 31, 2009 | 24.91M |
| December 31, 2008 | -58.79M |
| December 31, 2007 | 24.90M |
| December 31, 2006 | -1.747M |
| December 31, 2005 | 52.48M |
| December 31, 2004 | 117.96M |
| December 31, 2003 | 76.89M |
| December 31, 2001 | 2.744M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
196.11M
Minimum
2021
416.56M
Maximum
2019
291.07M
Average
239.97M
Median
2020
Shareholders Equity (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 431.76M |
| Sarepta Therapeutics Inc | 859.34M |
| ADMA Biologics Inc | 135.21M |
| Axsome Therapeutics Inc | 190.98M |
| Arcutis Biotherapeutics Inc | 88.67M |